These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3319272)

  • 1. Drug resistance and DNA repair.
    Fox M; Roberts JJ
    Cancer Metastasis Rev; 1987; 6(3):261-81. PubMed ID: 3319272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylation damage in DNA and RNA--repair mechanisms and medical significance.
    Drabløs F; Feyzi E; Aas PA; Vaagbø CB; Kavli B; Bratlie MS; Peña-Diaz J; Otterlei M; Slupphaug G; Krokan HE
    DNA Repair (Amst); 2004 Nov; 3(11):1389-407. PubMed ID: 15380096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
    Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
    Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair: enzymatic mechanisms and relevance to drug response.
    Chaney SG; Sancar A
    J Natl Cancer Inst; 1996 Oct; 88(19):1346-60. PubMed ID: 8827012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of the in vitro repair synthesis assay for probing the role of DNA repair in platinum resistance.
    Nichols AF; Schmidt WJ; Chaney SG; Sancar A
    Chem Biol Interact; 1992 Feb; 81(3):223-31. PubMed ID: 1540994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-specific repair of DNA damage induced by UV irradiation and cancer chemotherapeutics.
    Link CJ; Burt RK; Bohr VA
    Cancer Cells; 1991 Nov; 3(11):427-36. PubMed ID: 1760244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity.
    Saldivar JS; Wu X; Follen M; Gershenson D
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S56-71. PubMed ID: 17884153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing DNA repair capacity in bone marrow by gene transfer as a prospective tool in cancer therapy.
    Kleibl K; Margison GP
    Neoplasma; 1998; 45(4):181-6. PubMed ID: 9890659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Escherichia coli AlkB protein protects human cells against alkylation-induced toxicity.
    Chen BJ; Carroll P; Samson L
    J Bacteriol; 1994 Oct; 176(20):6255-61. PubMed ID: 7928996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair.
    Manic S; Gatti L; Carenini N; Fumagalli G; Zunino F; Perego P
    Curr Cancer Drug Targets; 2003 Feb; 3(1):21-9. PubMed ID: 12570658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of O6-methylguanine and methylphosphotriesters to the cytotoxicity of alkylating agents in mammalian cells.
    Hall J; Kataoka H; Stephenson C; Karran P
    Carcinogenesis; 1988 Sep; 9(9):1587-93. PubMed ID: 3409462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intragenomic heterogeneity of DNA damage formation and repair: a review of cellular responses to covalent drug DNA interaction.
    Wassermann K
    Crit Rev Toxicol; 1994; 24(4):281-322. PubMed ID: 7857520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic drug resistance and DNA repair.
    Burt RK; Poirier MC; Link CJ; Bohr VA
    Ann Oncol; 1991 May; 2(5):325-34. PubMed ID: 1954176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA adducts from chemotherapeutic agents.
    Lawley PD; Phillips DH
    Mutat Res; 1996 Aug; 355(1-2):13-40. PubMed ID: 8781575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation and correction of a mammalian cell mutant defective in late step of base excision repair.
    Ryan AJ; Hall M; Bouffler SD; Evans AL; Coates JA; Johnson RT
    Somat Cell Mol Genet; 1992 Nov; 18(6):529-41. PubMed ID: 1287851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
    Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML
    Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.
    Farrell NP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):1-9. PubMed ID: 15726528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.